Chemotherapy-induced neuropathic pain
- 1 March 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Supportive & Palliative Care
- Vol. 5 (1), 1-7
- https://doi.org/10.1097/spc.0b013e328342f9cc
Abstract
To discuss the importance, clinical features, possible pathology and treatments of chemotherapy-induced neuropathic pain. Newer biological agents such as bortezomib will be considered in greater detail. Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent complication of common anticancer therapies. It may lead to treatment compromise, significantly adds to the symptom burden and interferes with quality of life of cancer survivors. Recent investigations have identified processes involved in CIPN which may give some insight for the development of novel treatments. CIPN induced by different anticancer therapies may be heterogeneous and present as distinct neuropathic pains. Recent work has focussed on the newer anticancer drugs such as bortezomib. Contemporaneous studies have failed to find good evidence for the use of several common antineuropathic agents and further research is required. Painful CIPN remains under recognized and undertreated. It is an important cause of pain during cancer treatment and is a common pain in the cancer survivor. Difficulties in assessment and limitations in treatment contribute to management problems. Improvements in education (patient and clinician), assessment and treatment would potentially reduce the often debilitating effects of painful CIPN.Keywords
This publication has 62 references indexed in Scilit:
- Patient Perceptions Associated With Chemotherapy-Induced Peripheral NeuropathyClinical Journal of Oncology Nursing, 2010
- Chemotherapy-Induced Peripheral Neuropathy as a Predictor of Neuropathic Pain in Breast Cancer Patients Previously Treated With PaclitaxelThe Journal of Pain, 2009
- Role of MAPKs in platinum-induced neuronal apoptosisNeuroToxicology, 2009
- MAP kinase and painBrain Research Reviews, 2008
- Chronic Pain in the Cancer Survivor: A New FrontierPain Medicine, 2007
- Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunctionPain, 2006
- Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapiesSupportive Care in Cancer, 2004
- Pitfalls in grading severity of chemotherapy-induced peripheral neuropathyAnnals of Oncology, 1998
- Colchicine treatment of the sciatic nerve reduces neurogenic extravasation, but does not affect nociceptive thresholds or collateral sprouting in neuropathic or normal ratsPain, 1998
- Randomized trials with quality of life endpoints: Are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?Quality of Life Research, 1997